You are here


SGX queries Biolidics on timing of disclosure that authorities had approved its Covid-19 test kits

Medical technology firm says it made disclosure after it was certain kits could be commercialised

The Catalist-listed firm says the provisional authorisation from the Health Sciences Authority will allow the firm to export the product and market it in Singapore.


BIOLIDICS Ltd believes that it only became material to disclose that the firm had received approval for its virus test kits from Singapore's Health Sciences Authority (HSA) after it was certain that the kits could be commercialised.

In an exchange filing on Thursday, the...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to